Bank Of New York Mellon Corp Adaptive Biotechnologies Corp Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$2.88 - $4.8 $56,557 - $94,262	-19,638 Reduced 4.73%	395,344 $1.27 Billion
Q4 2023 Jan 29, 2024	BUY	$3.46 - $5.33 $135,196 - $208,264	39,074 Added 10.39%	414,982 $2.03 Billion
Q3 2023 Oct 24, 2023	BUY	$5.07 - $8.44 $11,787 - $19,623	2,325 Added 0.62%	375,908 $2.05 Billion
Q2 2023 Aug 03, 2023	SELL	$6.19 - $8.78 $47,192 - $66,938	-7,624 Reduced 2.0%	373,583 $2.51 Billion
Q1 2023 May 09, 2023	BUY	$7.8 - $10.11 $2.97 Million - $3.85 Million	381,207 New	381,207 $3.37 Billion
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $2.45 Million - $3.66 Million	391,563 New	391,563 $2.99 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $122,830 - $239,424	18,897 Added 4.98%	398,331 $2.84 Million
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $3.37 Million - $7.75 Million	-526,335 Reduced 58.11%	379,434 $3.07 Million
Q1 2022 May 11, 2022	SELL	$10.12 - $28.9 $236,990 - $676,780	-23,418 Reduced 2.52%	905,769 $12.6 Million
Q4 2021 Feb 11, 2022	SELL	$25.17 - $36.85 $54,996 - $80,517	-2,185 Reduced 0.23%	929,187 $26.1 Million
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $776,587 - $1.03 Million	25,869 Added 2.86%	931,372 $31.7 Million
Q2 2021 Aug 11, 2021	BUY	$32.22 - $44.59 $1.09 Million - $1.51 Million	33,928 Added 3.89%	905,503 $37 Million
Q1 2021 May 13, 2021	BUY	$37.26 - $67.74 $150,604 - $273,805	4,042 Added 0.47%	871,575 $35.1 Million
Q4 2020 Feb 09, 2021	BUY	$45.01 - $65.47 $3.78 Million - $5.49 Million	83,916 Added 10.71%	867,533 $51.3 Million
Q3 2020 Nov 12, 2020	BUY	$35.79 - $48.81 $2.77 Million - $3.77 Million	77,282 Added 10.94%	783,617 $38.1 Million
Q2 2020 Aug 12, 2020	BUY	$24.95 - $48.38 $14 Million - $27.2 Million	562,170 Added 389.95%	706,335 $34.2 Million
Q1 2020 May 06, 2020	BUY	$16.96 - $34.16 $1.73 Million - $3.48 Million	101,849 Added 240.69%	144,165 $4 Million
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $285,043 - $380,676	11,606 Added 37.79%	42,316 $1.27 Million
Q3 2019 Nov 07, 2019	BUY	$30.31 - $53.51 $930,820 - $1.64 Million	30,710 New	30,710 $948,000

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

Viking Global Investors LP

30M
Shares

$178 Million
0.59% of portfolio
Rubric Capital Management LP New York, NY

14.4M
Shares

$85.5 Million
2.05% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$69.3 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.6M
Shares

$68.9 Million
0.56% of portfolio
Vanguard Group Inc Valley Forge, PA

10.6M
Shares

$63.2 Million
0.0% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account